Come and join us across the globe
Sign In

Right-sided paraophthalmic aneurysm treated with a Pipeline™ Vantage Shield using RIST™ Radial access System

Last update on October 11, 2021

Find out how Dr. Riitta Rautio (Turku University Hospital, Finland) treated a 66-year-old female patient suffering from TGA symptoms.

CASE PRESENTATION

  • Previously healthy 66-year-old female patient.
  • MRI was performed due to TGA symptoms.
  • Incidental right paraophthalmic internal carotid artery aneurysm discovered.
  • MIP reconstruction of a 3D rotational DSA demonstrated a laterally and cranially projecting wide-necked aneurysm.
  • The 3D image showed that the ophtalmic artery orifice (arrow) is not engaged in the aneurysm neck.

 

Incidental right paraophthalmic internal carotid artery aneurysm

 

TREATMENT STRATEGY

  • This is one of our first Vantage & RIST™ cases.
  • Very easy handling with the RIST™ system already from the beginning.
  • Right radial puncture was performed in ultrasound guidance.
  • Short Terumo Slender 7F sheath inserted.
  • Rist™ 5 Fr Sim2 130 cm select catheter was telescoped inside a 079 Rist™ 100 cm guide catheter over a 0.035 Terumo wire.
  • After reforming the Simmons curve of the Rist™ catheter in the aorta, the proximal right CCA was easily catheterized.

 

You do not have permission to view this object.

 

 

  • Terumo wire was advanced into the distal petrous ICA while keeping the select catheter hooked at the CCA origin.
  • The Rist™ guide catheter was advanced over the Terumo wire to the petrous ICA.
  • Before removing the select catheter, the DSA images were taken.
  • Here are the AP and lateral runs before the procedure. 

 

You do not have permission to view this object.
You do not have permission to view this object.

 

  • Distal end of the 079 Rist™ guide catheter is marked with a red arrow.

 

Distal end of the 079 Rist guide catheter

 

  • FD sizing was performed on the basis of measurements of the artery, acquired from the 3D rotational angiography data.
  • In addition to manual measurements, virtual sizing with the Sim&Size® simulation was performed.
  • Pipeline™ Vantage Shield 4 x 16 mm device was chosen.
  • The simulation showed that both distal and proximal ends would land on a straight vessel segment.
  • The patient had started with Prasugrel 5 mg and aspirin 100 mg 5 days before the procedure.
  • Platelet function was evaluated by Multiplate Analyzer (Roche Diagnostics, Mannheim, Germany) before the procedure.
  • During the procedure, activated clotting time (ACT) was doubled by administering a heparin bolus and ACT controlled at 30 – 45 minutes intervals. After the procedure, heparinization was neither antagonized nor maintained.
  • Prasugrel and aspirin continued for at least 3 months, until the first DSA-control.

 

You do not have permission to view this object.

 

  • The distal part of the Vantage was already nicely opposed to the vessel wall. Aneurysm neck was covered as well.
  • We opened the mid-proximal part of Vantage in the curve. Some tension is constructed in order to open the device properly.
  • An intermediate catheter would probably have smoothened the opening.
  • After this case, we have always used an intermediate catheter-like Navien 058.

 

You do not have permission to view this object.
You do not have permission to view this object.

 

  • Arrow is pointing to the ”point of no return” in the beginning of the video.

 

point of no return

 

  • First fluoroscopy was run to show the proximal opening and another fluoroscopy was run to show how smoothly the 027 Phenom microcatheter was advanced through the device after opening it. 

 

Final run after procedure

 

  • These images were captured from the final run after the procedure.
  • The wall apposition was achieved nicely.
  • There was no contrast stagnation in the aneurysm yet.
  • The patient was discharged the next day in good clinical condition. 

 

RESULTS

  • Here we have the 3-month DSA follow-up. The aneurysm is still filling with contrast, but there is remarkable stagnation now visible and almost no intima hyperplasia. 
  • The patient continues with aspirin only and we will do a new DSA in three months
  • The DSA control was done via radial access of course.

 

You do not have permission to view this object.

 

This case is sponsored by Medtronic.

On the same subject
Come and join us across the globe